Note from Director

A Message from Our Director

Laura Marcu Director
Laura Marcu, PhD
Director, National Center for Interventional Biophotonic Technologies (NCIBT)

Welcome to the National Center for Interventional Biophotonic Technologies!

Advances in biomedical imaging are transforming our ability to evaluate human tissue, physiology, and disease. Yet their greatest clinical impact will come when this information can be delivered in real time, at the point of intervention, and translated into actionable insights that help clinicians make better-informed decisions for their patients.

At NCIBT, our vision is to create a new technological paradigm for image-guided medical decision-making. We are developing technologies that provide clinicians with real-time information about tissue composition, physiology, and pathology and integrate these data with preprocedural and intraprocedural imaging and other relevant clinical information. Our goal is to deliver actionable information when it matters most—during the intervention itself.

NCIBT brings together complementary expertise in Interventional Fluorescence Lifetime Imaging (iFLIM), Interferometric Diffuse Optical Spectroscopy (iDOS), and artificial intelligence, data analytics, and visualization. Through our three Technology Research and Development (TRD) programs and a nationally distributed network of Collaborative and Service Projects, we are advancing these technologies, evaluating them across diverse biomedical and clinical applications, and integrating them into a new generation of scalable optical systems and intelligent analytical and visualization tools for a broad range of clinical interventions.

A defining strength of NCIBT is the close integration of engineering, optical sciences, computation, and medicine. By bringing together engineers, scientists, clinicians, trainees, and industry partners, we seek not only to develop innovative technologies but also to accelerate their validation, clinical translation, dissemination, and adoption across the broader biomedical community.

Ultimately, our mission extends beyond developing new imaging instruments. We aim to create and disseminate technologies that provide clinicians with the right information, at the right time, during an intervention—enabling more precise diagnosis, treatment, and monitoring and, ultimately, improving patient outcomes.

I invite you to explore our website to learn more about our technologies, Collaborative and Service Projects, clinical translation, training and dissemination programs, and the growing NCIBT community. We welcome new collaborations and opportunities to make these technologies broadly accessible to investigators and clinicians and to advance the future of image-guided interventions.